Identifying Low-Abundance Biomarkers: Aptamer-Based Proteomics Potentially Enables More Sensitive Detection in Cardiovascular Diseases

Affiliations

• ¹ From Department of Physiology, Ted Rogers Centre for Heart Research, University of Toronto, Canada (A.G., P.P.L.); NIH BD2K Center of Excellence in Biomedical Computing, Department of Physiology, UCLA David Geffen School of Medicine, Los Angeles, CA (E.L.); and University of Ottawa Heart Institute, Departments of Medicine & Cellular Molecular Medicine, University of Ottawa, Canada (P.P.L.).
• ² From Department of Physiology, Ted Rogers Centre for Heart Research, University of Toronto, Canada (A.G., P.P.L.); NIH BD2K Center of Excellence in Biomedical Computing, Department of Physiology, UCLA David Geffen School of Medicine, Los Angeles, CA (E.L.); and University of Ottawa Heart Institute, Departments of Medicine & Cellular Molecular Medicine, University of Ottawa, Canada (P.P.L.). peter.liu@utoronto.ca pliu@ottawaheart.ca edward.lau@me.com.